CJC-1295 NO DAC (Mod GRF 1-29) (5mg)
$48.00$41.00
CJC-1295 NO DAC, also known as Modified GRF (1-29), is a synthetic peptide that's being researched for its potential to stimulate the release of growth hormone (GH). It is a modified, 29-amino-acid fragment of the naturally occurring Growth Hormone-Releasing Hormone (GHRH). Unlike its DAC counterpart, this version does not have the Drug Affinity Complex, which gives it a shorter half-life but still allows for potential research applications, particularly in combination with other peptides.
Product Specifications
Specification | Details |
SKU | P-MODGRF129 |
Purity | >99% |
Form | Lyophilized Powder |
Size | 5 mg |
Contents | CJC-1295 NO DAC (MOD GRF 1-29) |
Pricing
Free shipping on all orders over $200!
Quantity | Discount | Price (USD) |
5 - 8 | 5% | $38.95 |
9+ | 10% | $36.90 |
Chemical Makeup
Specification | Details |
Molecular Formula | C152H252N44O42 |
Molecular Weight | 3367.9 g/mol |
Other Known Titles | CJC-1295 Without DAC, Modified GRF (1-29) |
Research and Clinical Studies
GH Pulsatility
Research suggests that CJC-1295 NO DAC may have a significant effect on the growth hormone-IGF-1 axis. A study reported a substantial increase in mean 12-hour GH release by 70-107% and a concurrent increase in insulin-like growth factor 1 (IGF-1) by approximately 28%. This suggests a potential role for the peptide in promoting skin cell proliferation and muscle tissue hypertrophy.
Peptide Combinations
CJC-1295 NO DAC is often researched in combination with other peptides, particularly growth hormone secretagogues (GHSs) like Ipamorelin. GHSs are believed to act on different receptors (ghrelin receptors) than CJC-1295 (GHRH receptors), and research suggests that their simultaneous activation on pituitary cells may lead to a synergistic increase in growth hormone secretion.
Ancillary Research
Intestinal Studies: Research on GHRH analog peptides suggests a potential interaction with VPAC(1)-R receptors on the smooth muscles of the gastrointestinal system, which may induce bowel movement.
Heart Rate: Preliminary research suggests that GHRH analogs like CJC-1295 NO DAC may help stabilize heart rate and improve the heart's ability to pump blood, especially after a heart attack. The peptide appeared to promote cardiac tissue repair and improve ejection fraction rates.
Disclaimer: CJC-1295 peptide is available for research and laboratory purposes only.
